PATENT CLAIM ANALYSIS

Application Number: 16122360
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-02
Patent Classification: ["424", "451000"]

Abstract:
Abuse-resistant therapeutic pharmaceutical formulations include a cationic drug and at least one anionic polymer. Particular arrangements of the cationic drug and the at least one anionic polymer prevent the cationic drug from being extracted from the formulations in solvents and conditions commonly used by drug abusers attempting to isolate the cationic drug from its formulation.

Claim (Index 12):
The pharmaceutical formulation of  claim 11 , wherein the at least one anionic polymer comprises a poly(acrylic acid) homopolymer, copolymer, terpolymer, or interpolymer.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 97.0
- Lexical Diversity: 1.62857
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14589839', '14704836', '14841428', '15076253', '10607446']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7284010411608779
- 35 USC 102 Novelty (BERT): 0.4655521884128446
- Combined Prediction Score: 0.7021161558860746
- Mean Citation Score: 230.719124
- Max Citation Score: 240.37888
- Similarity Product: 199.28638376770024

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test